Pub Date : 2021-10-29eCollection Date: 2021-01-01DOI: 10.1155/2021/5599129
Jonathan Katsukunya, Rumbidzai Makurira, Stanley Mukanganyama
Treatment of infections caused by S. aureus has become a challenge due to the emergency of resistant strains. Ozoroa reticulata root extracts have been used in traditional medicine to treat throat and chest pains in Zimbabwe. The objective of the study was to determine the effects of O. reticulata root bark extracts on the production of extracellular proteases by S. aureus. The root barks were collected, dried, and crushed into powder. To obtain different phytoconstituents, plant extractions were performed. Extractions were carried out using two solvent mixtures: ethanol : water (50 : 50 v/v) and dichloromethane : methanol (50 : 50 v/v). Serial exhaustive extractions were also performed using methanol, ethanol, dichloromethane, acetone, ethyl acetate, hexane, and water. The broth microdilution assays were used to assess the antibacterial effects of the Ozoroa reticulata root bark extracts against S. aureus. Ciprofloxacin was used as a positive control. Qualitative screening for extracellular protease production by S. aureus on BCG-skim milk agar plates using the most potent extract was carried out. The proteolytic zones were measured and expressed as the ratio of the diameter of the colony to the total diameter of the colony plus the zone of hydrolysis (Pz values). The ethyl acetate extract was found to be the most potent inhibitor of the growth of S. aureus with 99% inhibition and a minimum inhibitory concentration (MIC) of 100 µg/mL. Inhibition of extracellular protease production was directly proportional to the concentration of the extract. At 100 µg/mL, the ethyl acetate extract had a Pz value of 0.84, indicative of mild proteolytic activity. A Pz value of 0.94 was observed at a concentration of 200 µg/mL and signified weak proteolytic activity. In conclusion, the extract inhibited the production of extracellular proteases in S. aureus. Further work on the isolation and purification of bioactive compounds responsible for inhibiting the production of extracellular proteases is of importance in the discovery of agents with antivirulent effects on S. aureus.
由于耐药菌株的紧急出现,治疗由金黄色葡萄球菌引起的感染已成为一项挑战。在津巴布韦,Ozoroa reticulata 根提取物一直被用于治疗喉咙和胸痛的传统医学中。本研究的目的是确定 O. reticulata 根皮提取物对金黄色葡萄球菌产生胞外蛋白酶的影响。采集根皮,将其干燥并碾成粉末。为了获得不同的植物成分,进行了植物萃取。萃取使用两种混合溶剂:乙醇:水(50:50 v/v)和二氯甲烷:甲醇(50:50 v/v)。此外,还使用甲醇、乙醇、二氯甲烷、丙酮、乙酸乙酯、正己烷和水进行了连续穷举提取。肉汤微量稀释法用于评估 Ozoroa 网纹根树皮提取物对金黄色葡萄球菌的抗菌效果。环丙沙星用作阳性对照。在卡介苗-金黄色葡萄球菌琼脂平板上,使用最有效的提取物对金黄色葡萄球菌产生的胞外蛋白酶进行定性筛选。对蛋白水解区进行了测量,并以菌落直径与菌落直径加水解区总直径之比(P z 值)表示。研究发现,乙酸乙酯提取物是金黄色葡萄球菌生长的最有效抑制剂,抑制率达 99%,最低抑制浓度 (MIC) 为 100 µg/mL。对细胞外蛋白酶生成的抑制作用与提取物的浓度成正比。当浓度为 100 µg/mL 时,乙酸乙酯提取物的 P z 值为 0.84,表明其具有轻微的蛋白水解活性。浓度为 200 µg/mL 时,P z 值为 0.94,表明蛋白水解活性较弱。总之,该提取物抑制了金黄色葡萄球菌胞外蛋白酶的产生。进一步分离和纯化能抑制细胞外蛋白酶产生的生物活性化合物,对于发现对金黄色葡萄球菌具有抗病毒作用的制剂具有重要意义。
{"title":"<i>Ozoroa insignis reticulata</i> (Baker f.) R. Fern. & A. Fern. Root Extract Inhibits the Production of Extracellular Proteases by <i>Staphylococcus aureus</i>.","authors":"Jonathan Katsukunya, Rumbidzai Makurira, Stanley Mukanganyama","doi":"10.1155/2021/5599129","DOIUrl":"10.1155/2021/5599129","url":null,"abstract":"<p><p>Treatment of infections caused by <i>S. aureus</i> has become a challenge due to the emergency of resistant strains. <i>Ozoroa reticulata</i> root extracts have been used in traditional medicine to treat throat and chest pains in Zimbabwe. The objective of the study was to determine the effects of <i>O. reticulata</i> root bark extracts on the production of extracellular proteases by <i>S. aureus</i>. The root barks were collected, dried, and crushed into powder. To obtain different phytoconstituents, plant extractions were performed. Extractions were carried out using two solvent mixtures: ethanol : water (50 : 50 v/v) and dichloromethane : methanol (50 : 50 v/v). Serial exhaustive extractions were also performed using methanol, ethanol, dichloromethane, acetone, ethyl acetate, hexane, and water. The broth microdilution assays were used to assess the antibacterial effects of the <i>Ozoroa reticulata</i> root bark extracts against <i>S. aureus</i>. Ciprofloxacin was used as a positive control. Qualitative screening for extracellular protease production by <i>S. aureus</i> on BCG-skim milk agar plates using the most potent extract was carried out. The proteolytic zones were measured and expressed as the ratio of the diameter of the colony to the total diameter of the colony plus the zone of hydrolysis (<i>P</i> <sub><i>z</i></sub> values). The ethyl acetate extract was found to be the most potent inhibitor of the growth of <i>S. aureus</i> with 99% inhibition and a minimum inhibitory concentration (MIC) of 100 <i>µ</i>g/mL. Inhibition of extracellular protease production was directly proportional to the concentration of the extract. At 100 <i>µ</i>g/mL, the ethyl acetate extract had a <i>P</i> <sub><i>z</i></sub> value of 0.84, indicative of mild proteolytic activity. A <i>P</i> <sub><i>z</i></sub> value of 0.94 was observed at a concentration of 200 <i>µ</i>g/mL and signified weak proteolytic activity. In conclusion, the extract inhibited the production of extracellular proteases in <i>S. aureus</i>. Further work on the isolation and purification of bioactive compounds responsible for inhibiting the production of extracellular proteases is of importance in the discovery of agents with antivirulent effects on <i>S. aureus</i>.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"5599129"},"PeriodicalIF":3.4,"publicationDate":"2021-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570894/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39597982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-10-22eCollection Date: 2021-01-01DOI: 10.1155/2021/1383830
Adil R Sarhan, Thaer A Hussein, Mohammed H Flaih, Khwam R Hussein
Several studies have demonstrated that age, comorbidities, and abnormalities in different clinical biomarkers can be important to understand disease severity. Although clinical features of COVID-19 have been widely described, the assessment of alterations of the most common biochemical markers that are reported in patients with COVID-19 still has not been well established. Here, we report clinical and blood biochemical indicators of 100 patients with COVID-19. Throat-swab upper respiratory samples were obtained from patients and real-time PCR was used to confirm SARS-CoV-2 infection. Gender, age, and clinical features such as diabetes mellitus, hypertension, and smoking habits were investigated. Biochemical parameters were categorized and analyzed according to these clinical characteristics. Triglycerides, GPT, and ALP are the biochemical markers that changed the most in the group of hypertension patients. Cholesterol and triglycerides were significantly different (P=0.01; P=0.04, respectively) between diabetic and nondiabetic patients with COVID-19. Potassium levels were significantly different (P=0.03) when comparing smokers with nonsmoker patients. Our results suggest several potential biochemical indexes that changed in patients with COVID-19 and whether certain comorbidity and clinical characteristics influence these markers.
{"title":"A Biochemical Analysis of Patients with COVID-19 Infection.","authors":"Adil R Sarhan, Thaer A Hussein, Mohammed H Flaih, Khwam R Hussein","doi":"10.1155/2021/1383830","DOIUrl":"10.1155/2021/1383830","url":null,"abstract":"<p><p>Several studies have demonstrated that age, comorbidities, and abnormalities in different clinical biomarkers can be important to understand disease severity. Although clinical features of COVID-19 have been widely described, the assessment of alterations of the most common biochemical markers that are reported in patients with COVID-19 still has not been well established. Here, we report clinical and blood biochemical indicators of 100 patients with COVID-19. Throat-swab upper respiratory samples were obtained from patients and real-time PCR was used to confirm SARS-CoV-2 infection. Gender, age, and clinical features such as diabetes mellitus, hypertension, and smoking habits were investigated. Biochemical parameters were categorized and analyzed according to these clinical characteristics. Triglycerides, GPT, and ALP are the biochemical markers that changed the most in the group of hypertension patients. Cholesterol and triglycerides were significantly different (<i>P</i>=0.01; <i>P</i>=0.04, respectively) between diabetic and nondiabetic patients with COVID-19. Potassium levels were significantly different (<i>P</i>=0.03) when comparing smokers with nonsmoker patients. Our results suggest several potential biochemical indexes that changed in patients with COVID-19 and whether certain comorbidity and clinical characteristics influence these markers.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"1383830"},"PeriodicalIF":3.0,"publicationDate":"2021-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542065/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39562512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-09-28eCollection Date: 2021-01-01DOI: 10.1155/2021/2854217
X E Mabasa, L M Mathomu, N E Madala, E M Musie, M T Sigidi
Momordica balsamina (M. balsamina) is a medicinal herb comprising health-promoting secondary metabolites. This study was aimed to profile bioactive compounds in the methanolic extract of M. balsamina leaves using molecular spectroscopic (UV-Vis and FTIR) and hyphenated chromatographic (UHPLC-qTOF-MS) techniques and evaluate the biological (in vitro anti-inflammatory and cytotoxicity) activities of the extract. The preliminary phytochemical screening tests revealed the presence of cardiac glycosides, flavonoids, saponins, tannins, and terpenoids. The UV-Vis profile revealed various absorption bands ranging from 200 to 750 nm, indicating the presence of flavonoids, phenolic compounds, tannins, terpenoids, carotenoids, chlorophyll, and alkaloids. FTIR spectra confirmed the presence of alkaloids, flavonoids, terpenes, anthraquinones, and phenolic compounds. A high-resolution and accurate mass spectrometer (LC-QTOF-MS model LC-MS-9030 instrument) was used, and the results confirmed the presence of flavonoid aglycones, such as quercetin, isorhamnetin, and kaempferol, as well as pseudolaroside A and dicaffeoylquinic and feruloyl isocitric acids. To the best of our knowledge, this is the first report of pseudolaroside A dimer and feruloyl isocitric acid in M. balsamina leaves. In vitro cytotoxicity assay showed that the extract was nontoxic against human colorectal adenocarcinoma (HT29 and Caco2), Vero, and RAW 264.7 cells. However, the extract showed anti-inflammatory activity on RAW 264.7 cells. The study confirmed that M. balsamina leaves contain nontoxic secondary metabolites that may play a pivotal role in human health as anti-inflammatory agents.
{"title":"Molecular Spectroscopic (FTIR and UV-Vis) and Hyphenated Chromatographic (UHPLC-qTOF-MS) Analysis and <i>In Vitro</i> Bioactivities of the <i>Momordica balsamina</i> Leaf Extract.","authors":"X E Mabasa, L M Mathomu, N E Madala, E M Musie, M T Sigidi","doi":"10.1155/2021/2854217","DOIUrl":"https://doi.org/10.1155/2021/2854217","url":null,"abstract":"<p><p><i>Momordica balsamina</i> (<i>M. balsamina</i>) is a medicinal herb comprising health-promoting secondary metabolites. This study was aimed to profile bioactive compounds in the methanolic extract of <i>M. balsamina</i> leaves using molecular spectroscopic (UV-Vis and FTIR) and hyphenated chromatographic (UHPLC-qTOF-MS) techniques and evaluate the biological (<i>in vitro</i> anti-inflammatory and cytotoxicity) activities of the extract. The preliminary phytochemical screening tests revealed the presence of cardiac glycosides, flavonoids, saponins, tannins, and terpenoids. The UV-Vis profile revealed various absorption bands ranging from 200 to 750 nm, indicating the presence of flavonoids, phenolic compounds, tannins, terpenoids, carotenoids, chlorophyll, and alkaloids. FTIR spectra confirmed the presence of alkaloids, flavonoids, terpenes, anthraquinones, and phenolic compounds. A high-resolution and accurate mass spectrometer (LC-QTOF-MS model LC-MS-9030 instrument) was used, and the results confirmed the presence of flavonoid aglycones, such as quercetin, isorhamnetin, and kaempferol, as well as pseudolaroside A and dicaffeoylquinic and feruloyl isocitric acids. To the best of our knowledge, this is the first report of pseudolaroside A dimer and feruloyl isocitric acid in <i>M. balsamina</i> leaves. <i>In vitro</i> cytotoxicity assay showed that the extract was nontoxic against human colorectal adenocarcinoma (HT29 and Caco2), Vero, and RAW 264.7 cells. However, the extract showed anti-inflammatory activity on RAW 264.7 cells. The study confirmed that <i>M. balsamina</i> leaves contain nontoxic secondary metabolites that may play a pivotal role in human health as anti-inflammatory agents.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"2854217"},"PeriodicalIF":3.0,"publicationDate":"2021-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492264/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39495962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-08-18eCollection Date: 2021-01-01DOI: 10.1155/2021/2319412
Min Chen, Li Peng, Ping Gong, Xiaoli Zheng, Tao Sun, Xiaoqiao Zhang, Jiangtao Huo
Parkinson's disease (PD) is regarded as a severe neurodegenerative disorder. Baicalein is involved in the treatment of PD. This study explored the mechanism of baicalein in PD. The PD rat model was established using 6-hydroxydopamine. The neurologic score, dopamine (DA) content, apoptotic cells, and neuronal damage were evaluated after rats were treated with baicalein. Autophagy in PD rats was inhibited using 3-methyladenine (3-MA). The mitochondrial membrane potential (MMP) and autophagy-related proteins (LC3, P62) were detected. Next, agomiR-30b was transfected into PD rats. The targeting relation between miR-30b and NIX was predicted and verified. Then, sh-NIX was transfected into PD rats, and the effects of miR-30b and NIX on MMP, LC3, and P62 were assessed. When miR-30b was overexpressed using agomiR-30b, the NIX and BNIP3 levels were detected. Baicalein increased the neurological score and restored DA content, neurons, MMP, and mitochondrial autophagy protein levels. Baicalein inhibited miR-30b expression and miR-30b targeted NIX. miR-30b upregulation or NIX silencing reversed the effect of baicalein on MMP and mitochondrial autophagy. Baicalein upregulated NIX and BNIP3 expressions, while miR-30b overexpression inhibited NIX and BNIP3 expressions. In summary, baicalein mediated mitochondrial autophagy and restored neuronal activity by downregulating miR-30b and activating the NIX/BNIP3 pathway, thus protecting against PD.
{"title":"Baicalein Mediates Mitochondrial Autophagy via miR-30b and the NIX/BNIP3 Signaling Pathway in Parkinson's Disease.","authors":"Min Chen, Li Peng, Ping Gong, Xiaoli Zheng, Tao Sun, Xiaoqiao Zhang, Jiangtao Huo","doi":"10.1155/2021/2319412","DOIUrl":"https://doi.org/10.1155/2021/2319412","url":null,"abstract":"<p><p>Parkinson's disease (PD) is regarded as a severe neurodegenerative disorder. Baicalein is involved in the treatment of PD. This study explored the mechanism of baicalein in PD. The PD rat model was established using 6-hydroxydopamine. The neurologic score, dopamine (DA) content, apoptotic cells, and neuronal damage were evaluated after rats were treated with baicalein. Autophagy in PD rats was inhibited using 3-methyladenine (3-MA). The mitochondrial membrane potential (MMP) and autophagy-related proteins (LC3, P62) were detected. Next, agomiR-30b was transfected into PD rats. The targeting relation between miR-30b and NIX was predicted and verified. Then, sh-NIX was transfected into PD rats, and the effects of miR-30b and NIX on MMP, LC3, and P62 were assessed. When miR-30b was overexpressed using agomiR-30b, the NIX and BNIP3 levels were detected. Baicalein increased the neurological score and restored DA content, neurons, MMP, and mitochondrial autophagy protein levels. Baicalein inhibited miR-30b expression and miR-30b targeted NIX. miR-30b upregulation or NIX silencing reversed the effect of baicalein on MMP and mitochondrial autophagy. Baicalein upregulated NIX and BNIP3 expressions, while miR-30b overexpression inhibited NIX and BNIP3 expressions. In summary, baicalein mediated mitochondrial autophagy and restored neuronal activity by downregulating miR-30b and activating the NIX/BNIP3 pathway, thus protecting against PD.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"2319412"},"PeriodicalIF":3.0,"publicationDate":"2021-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390153/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39380584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-07-27eCollection Date: 2021-01-01DOI: 10.1155/2021/9987990
Jun Yang, Ying Zhang, Jiaying Zhou, Shaohua Wang
Background: Neuroblastoma is a malignant neuroendocrine tumor from the sympathetic nervous system, the most common extracranial tumor in children. Identifying potential prognostic markers of neuroblastoma can provide clues for early diagnosis, recurrence, and treatment.
Methods: RNA sequence data and clinical features of 147 neuroblastomas were obtained from the TARGET (Therapeutically Applicable Research to Generate Effective Treatments project) database. Application weighted gene coexpression network analysis (WGCNA) was used to construct a free-scale gene coexpression network, to study the interrelationship between its potential modules and clinical features, and to identify hub genes in the module. We performed Lasso regression and Cox regression analyses to identify the three most important genes and develop a new prognostic model. Data from the GSE85047 cohort verified the predictive accuracy of the prognostic model.
Results: 14 coexpression modules were constructed using WGCNA. Brown coexpression modules were found to be significantly associated with disease survival status. Multivariate Cox analysis was performed on genes from univariate Cox regression and Lasso regression analyses using the Cox proportional hazards regression model. Finally, we constructed a three-gene prognostic model: risk score = (0.003812659∗CKB) + (-0.152376975∗expDST) + (0.032032815∗expDUT). The prognosis of samples in the high-risk group was significantly poorer than that of samples in the low-risk group (P=1.225e - 06). The risk model was also regarded as an independent predictor of prognosis (HR = 1.632; 95% CI = 1.391-1.934; P < 0.001).
Conclusion: Our study constructed a neuroblastoma coexpressing gene module and identified a prognostic potential risk model for prognosis in neuroblastoma.
背景:神经母细胞瘤是一种来自交感神经系统的恶性神经内分泌肿瘤,是儿童最常见的颅外肿瘤。识别神经母细胞瘤的潜在预后标记可以为早期诊断、复发和治疗提供线索。方法:从TARGET (Therapeutically applied Research to Generate Effective therapies project)数据库中获取147例神经母细胞瘤的RNA序列数据和临床特征。应用加权基因共表达网络分析(WGCNA)构建自由尺度基因共表达网络,研究其潜在模块与临床特征之间的相互关系,并识别模块中的枢纽基因。我们通过Lasso回归和Cox回归分析来确定三个最重要的基因,并建立了一个新的预后模型。来自GSE85047队列的数据验证了预后模型的预测准确性。结果:WGCNA共构建了14个共表达模块。发现棕色共表达模块与疾病生存状态显著相关。采用Cox比例风险回归模型对基因进行单因素Cox回归和Lasso回归分析。最后,我们构建了一个三基因预后模型:风险评分=(0.003812659∗CKB) +(-0.152376975∗expDST) +(0.032032815∗expDUT)。高危组患者预后明显差于低危组患者(P=1.225e - 06)。风险模型也被认为是预后的独立预测因子(HR = 1.632;95% ci = 1.391-1.934;P < 0.001)。结论:本研究构建了神经母细胞瘤共表达基因模块,确定了神经母细胞瘤预后的预后潜在风险模型。
{"title":"Identification of Prognostic Genes in Neuroblastoma in Children by Weighted Gene Coexpression Network Analysis.","authors":"Jun Yang, Ying Zhang, Jiaying Zhou, Shaohua Wang","doi":"10.1155/2021/9987990","DOIUrl":"https://doi.org/10.1155/2021/9987990","url":null,"abstract":"<p><strong>Background: </strong>Neuroblastoma is a malignant neuroendocrine tumor from the sympathetic nervous system, the most common extracranial tumor in children. Identifying potential prognostic markers of neuroblastoma can provide clues for early diagnosis, recurrence, and treatment.</p><p><strong>Methods: </strong>RNA sequence data and clinical features of 147 neuroblastomas were obtained from the TARGET (Therapeutically Applicable Research to Generate Effective Treatments project) database. Application weighted gene coexpression network analysis (WGCNA) was used to construct a free-scale gene coexpression network, to study the interrelationship between its potential modules and clinical features, and to identify hub genes in the module. We performed Lasso regression and Cox regression analyses to identify the three most important genes and develop a new prognostic model. Data from the GSE85047 cohort verified the predictive accuracy of the prognostic model.</p><p><strong>Results: </strong>14 coexpression modules were constructed using WGCNA. Brown coexpression modules were found to be significantly associated with disease survival status. Multivariate Cox analysis was performed on genes from univariate Cox regression and Lasso regression analyses using the Cox proportional hazards regression model. Finally, we constructed a three-gene prognostic model: risk score = (0.003812659<i>∗</i>CKB) + (-0.152376975<i>∗</i>expDST) + (0.032032815<i>∗</i>expDUT). The prognosis of samples in the high-risk group was significantly poorer than that of samples in the low-risk group (<i>P</i>=1.225<i>e</i> - 06). The risk model was also regarded as an independent predictor of prognosis (HR = 1.632; 95% CI = 1.391-1.934; <i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>Our study constructed a neuroblastoma coexpressing gene module and identified a prognostic potential risk model for prognosis in neuroblastoma.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"9987990"},"PeriodicalIF":3.0,"publicationDate":"2021-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39280036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The aims of this study are to investigate the effect of acrylamide on the level of proinflammatory cytokines in the blood of acrylamide-treated rats and to find the modulatory impact of probiotics on those cytokines. Thirty-two rats were divided into four groups: rats which received 20 mg acrylamide, acrylamide with 20 mg probiotics, acrylamide with 200 mg probiotics, and standard water and food (groups 1-4, respectively). The serum levels of cytokines were measured on days 0, 15, and 30. Group 1 showed an increased serum level of IL-1β, IL-6, and TNF-α after 15 days, and they decreased in day 30. Serum IL-6 level was significantly decreased on days 15 and 30 in rats in group 2 compared to the controls. TNF-α and IL-1β levels were not statistically different after treated with probiotics. The exposure of rats to acrylamide led to increased systemic inflammation as evidenced by higher levels of proinflammatory cytokines, and probiotics can modulate this inflammation.
{"title":"Modulatory Effect of Probiotics on Proinflammatory Cytokine Levels in Acrylamide-Treated Rats.","authors":"Seyed Mohammad Seifati, Erfan Zaker, Farzaneh Fesahat, Fateme Zare, Seyedhossein Hekmatimoghaddam","doi":"10.1155/2021/2268770","DOIUrl":"https://doi.org/10.1155/2021/2268770","url":null,"abstract":"<p><p>The aims of this study are to investigate the effect of acrylamide on the level of proinflammatory cytokines in the blood of acrylamide-treated rats and to find the modulatory impact of probiotics on those cytokines. Thirty-two rats were divided into four groups: rats which received 20 mg acrylamide, acrylamide with 20 mg probiotics, acrylamide with 200 mg probiotics, and standard water and food (groups 1-4, respectively). The serum levels of cytokines were measured on days 0, 15, and 30. Group 1 showed an increased serum level of IL-1<i>β</i>, IL-6, and TNF-<i>α</i> after 15 days, and they decreased in day 30. Serum IL-6 level was significantly decreased on days 15 and 30 in rats in group 2 compared to the controls. TNF-<i>α</i> and IL-1<i>β</i> levels were not statistically different after treated with probiotics. The exposure of rats to acrylamide led to increased systemic inflammation as evidenced by higher levels of proinflammatory cytokines, and probiotics can modulate this inflammation.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"2268770"},"PeriodicalIF":3.0,"publicationDate":"2021-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318771/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39273452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-07-15eCollection Date: 2021-01-01DOI: 10.1155/2021/5596727
Ji-Gan Wang, Zhi-Juan Zhong, Meng Li, Jun Fu, Yu-Heng Su, You-Min Ping, Zi-Ji Xu, Hao Li, Yan-Hao Chen, Yu-Li Huang
Background: This study aimed to describe the clinical symptoms, laboratory findings, treatment, and outcomes of coronavirus disease 2019-related multisystem inflammatory syndrome in children to provide a reference for clinical practice.
Methods: We employed a literature search of databases such as PubMed, Web of Science, EMBASE, and Johns Hopkins University for articles on COVID-19-related multisystem inflammatory syndrome in children published between April 1, 2020, and January 15, 2021. High-quality articles were selected for analysis on the basis of their quality standard scores. Using R3.6.3 software, meta-analyses of random- or fixed-effects models were used to determine the prevalence of comorbidities. Subgroup analysis was also performed to determine heterogeneity.
Results: A total of 57 articles (2,290 pediatric patients) were included in the study. Clinical Manifestations. :ncidences of fever, gastrointestinal symptoms, respiratory symptoms, and musculoskeletal symptoms (myalgias or arthralgias) were 99.91% (95% CI: 99.67-100%), 82.72% (95% CI: 78.19-86.81%), 53.02% (45.28-60.68%), and 14.16% (95% CI: 8.4-21.12%), respectively. The incidences of rash, conjunctival injection, lymphadenopathy, dry cracked lips, neurologic symptoms (headache, altered mental status, or confusion), swollen hands and feet, typical Kawasaki disease, and atypical Kawasaki disease were 59.34% (95% CI: 54.73-63.87%), 55.23% (95% CI: 50.22-60.19%), 27.07% (95% CI: 19.87-34.93%), 46.37% (95% CI: 39.97-52.83%), 28.87% (95% CI: 22.76-35.40%), 28.75% (95% CI: 21.46-36.64%), 17.32% (95% CI: 15.44-19.29%), and 36.19% (95% CI: 21.90-51.86%), respectively. The incidences of coronary artery dilation, aneurysm, pericardial effusion, myocarditis, myocardial dysfunction, high troponin, and N-terminal pro-B-type natriuretic peptide were 17.83%, 6.85%, 20.97%, 35.97%, 56.32%, 76.34%, and 86.65%, respectively. The incidences of reduced lymphocytes, thrombocytopenia, hypoalbuminemia, elevated C-reactive protein, ferritin, LDH, interleukin-6, PCT, and FIB were 61.51%, 26.42%, 77.92%, 98.5%, 86.79%, 80.59%, 89.30%, 85.10%, and 87.01%, respectively. PICU Hospitalization Rate and Mortality. The incidences of PICU hospitalization or with shock were 72.79% and 55.68%, respectively. The mortality rate was 1.00%. Conclusion and Relevance. PICU hospitalization and shock rates of multisystem inflammatory syndrome in children associated with COVID-19 were high, and its cumulative multiorgans and inflammatory indicators are increased, but if treated in time, the mortality rate was low.
{"title":"Coronavirus Disease 2019-Related Multisystem Inflammatory Syndrome in Children: A Systematic Review and Meta-Analysis.","authors":"Ji-Gan Wang, Zhi-Juan Zhong, Meng Li, Jun Fu, Yu-Heng Su, You-Min Ping, Zi-Ji Xu, Hao Li, Yan-Hao Chen, Yu-Li Huang","doi":"10.1155/2021/5596727","DOIUrl":"https://doi.org/10.1155/2021/5596727","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to describe the clinical symptoms, laboratory findings, treatment, and outcomes of coronavirus disease 2019-related multisystem inflammatory syndrome in children to provide a reference for clinical practice.</p><p><strong>Methods: </strong>We employed a literature search of databases such as PubMed, Web of Science, EMBASE, and Johns Hopkins University for articles on COVID-19-related multisystem inflammatory syndrome in children published between April 1, 2020, and January 15, 2021. High-quality articles were selected for analysis on the basis of their quality standard scores. Using R3.6.3 software, meta-analyses of random- or fixed-effects models were used to determine the prevalence of comorbidities. Subgroup analysis was also performed to determine heterogeneity.</p><p><strong>Results: </strong>A total of 57 articles (2,290 pediatric patients) were included in the study. <i>Clinical Manifestations</i>. :ncidences of fever, gastrointestinal symptoms, respiratory symptoms, and musculoskeletal symptoms (myalgias or arthralgias) were 99.91% (95% CI: 99.67-100%), 82.72% (95% CI: 78.19-86.81%), 53.02% (45.28-60.68%), and 14.16% (95% CI: 8.4-21.12%), respectively. The incidences of rash, conjunctival injection, lymphadenopathy, dry cracked lips, neurologic symptoms (headache, altered mental status, or confusion), swollen hands and feet, typical Kawasaki disease, and atypical Kawasaki disease were 59.34% (95% CI: 54.73-63.87%), 55.23% (95% CI: 50.22-60.19%), 27.07% (95% CI: 19.87-34.93%), 46.37% (95% CI: 39.97-52.83%), 28.87% (95% CI: 22.76-35.40%), 28.75% (95% CI: 21.46-36.64%), 17.32% (95% CI: 15.44-19.29%), and 36.19% (95% CI: 21.90-51.86%), respectively. The incidences of coronary artery dilation, aneurysm, pericardial effusion, myocarditis, myocardial dysfunction, high troponin, and <i>N</i>-terminal pro-B-type natriuretic peptide were 17.83%, 6.85%, 20.97%, 35.97%, 56.32%, 76.34%, and 86.65%, respectively. The incidences of reduced lymphocytes, thrombocytopenia, hypoalbuminemia, elevated C-reactive protein, ferritin, LDH, interleukin-6, PCT, and FIB were 61.51%, 26.42%, 77.92%, 98.5%, 86.79%, 80.59%, 89.30%, 85.10%, and 87.01%, respectively. <i>PICU Hospitalization Rate and Mortality</i>. The incidences of PICU hospitalization or with shock were 72.79% and 55.68%, respectively. The mortality rate was 1.00%. <i>Conclusion and Relevance</i>. PICU hospitalization and shock rates of multisystem inflammatory syndrome in children associated with COVID-19 were high, and its cumulative multiorgans and inflammatory indicators are increased, but if treated in time, the mortality rate was low.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"5596727"},"PeriodicalIF":3.0,"publicationDate":"2021-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324361/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39273453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-07-06eCollection Date: 2021-01-01DOI: 10.1155/2021/9957490
Alexander M Zakharenko, Mayya P Razgonova, Konstantin S Pikula, Kirill S Golokhvast
The plant Rhodiola rosea L. of family Crassulaceae was extracted using the supercritical CO2-extraction method. Several experimental conditions were investigated in the pressure range of 200-500 bar, with the used volume of cosolvent ethanol in the amount of 1% in the liquid phase at a temperature in the range of 31-70°C. The most effective extraction conditions are pressure 350 bar and temperature 60°C. The extracts were analyzed by HPLC with MS/MS identification. 78 target analytes were isolated from Rhodiola rosea (Russia) using a series of column chromatography and mass spectrometry experiments. The results of the analysis showed a spectrum of the main active ingredients Rh. rosea: salidroside, rhodiolosides (B and C), rhodiosin, luteolin, catechin, quercetin, quercitrin, herbacetin, sacranoside A, vimalin, and others. In addition to the reported metabolites, 29 metabolites were newly annotated in Rh. rosea. There were flavonols: dihydroquercetin, acacetin, mearnsetin, and taxifolin-O-pentoside; flavones: apigenin-O-hexoside derivative, tricetin trimethyl ether 7-O-hexosyl-hexoside, tricin 7-O-glucoronyl-O-hexoside, tricin O-pentoside, and tricin-O-dihexoside; flavanones: eriodictyol-7-O-glucoside; flavan-3-ols: gallocatechin, hydroxycinnamic acid caffeoylmalic acid, and di-O-caffeoylquinic acid; coumarins: esculetin; esculin: fraxin; and lignans: hinokinin, pinoresinol, L-ascorbic acid, glucaric acid, palmitic acid, and linolenic acid. The results of supercritical CO2-extraction from roots and rhizomes of Rh. rosea, in particular, indicate that the extract contained all biologically active components of the plant, as well as inert mixtures of extracted compositions.
采用超临界co2萃取法提取了天竺葵科植物红景天。在压力为200- 500bar,液相共溶剂乙醇用量为1%,温度为31-70℃的条件下,研究了几种实验条件。最有效的提取条件是压力350巴,温度60℃。采用高效液相色谱-质谱联用技术对提取物进行分析。采用柱层析和质谱分析方法,从俄罗斯红景天中分离得到78种目标分析物。分析结果显示了主要有效成分Rh的谱图。玫瑰红:红景天苷、红景天苷(B和C)、红景天素、木犀草素、儿茶素、槲皮素、槲皮素、草菌素、沙果苷A、维马林等。除了已报道的代谢物外,在Rh中还新注释了29种代谢物。rosea。黄酮醇有:二氢槲皮素、金合欢素、马齿苋素和紫杉醇- o -戊苷;黄酮类化合物:芹菜素- o -己糖苷衍生物、三甲素三甲基醚7- o -己糖苷、三甲素- 7- o -己糖苷、三甲素- o -葡萄糖醛基- o -己糖苷、三甲素- o -戊糖苷和三甲素- o -二己糖苷;黄烷酮类:eriodictyol-7-O-glucoside;黄烷-3-醇:没食子儿茶素、羟基肉桂酸、咖啡酰苹果酸和二o -咖啡酰奎宁酸;香豆素类:七叶亭;七叶灵:fraxin;木脂素:牛蒡子素、松脂醇、l -抗坏血酸、葡萄糖酸、棕榈酸和亚麻酸。超临界co2萃取Rh根和根茎的结果。特别是玫瑰红,表明提取物含有该植物的所有生物活性成分,以及提取成分的惰性混合物。
{"title":"Simultaneous Determination of 78 Compounds of <i>Rhodiola rosea</i> Extract by Supercritical CO<sub>2</sub>-Extraction and HPLC-ESI-MS/MS Spectrometry.","authors":"Alexander M Zakharenko, Mayya P Razgonova, Konstantin S Pikula, Kirill S Golokhvast","doi":"10.1155/2021/9957490","DOIUrl":"https://doi.org/10.1155/2021/9957490","url":null,"abstract":"<p><p>The plant <i>Rhodiola rosea</i> L. of family <i>Crassulaceae</i> was extracted using the supercritical CO<sub>2</sub>-extraction method. Several experimental conditions were investigated in the pressure range of 200-500 bar, with the used volume of cosolvent ethanol in the amount of 1% in the liquid phase at a temperature in the range of 31-70°C. The most effective extraction conditions are pressure 350 bar and temperature 60°C. The extracts were analyzed by HPLC with MS/MS identification. 78 target analytes were isolated from <i>Rhodiola rosea</i> (Russia) using a series of column chromatography and mass spectrometry experiments. The results of the analysis showed a spectrum of the main active ingredients <i>Rh. rosea</i>: salidroside, rhodiolosides (B and C), rhodiosin, luteolin, catechin, quercetin, quercitrin, herbacetin, sacranoside A, vimalin, and others. In addition to the reported metabolites, 29 metabolites were newly annotated in <i>Rh. rosea.</i> There were flavonols: dihydroquercetin, acacetin, mearnsetin, and taxifolin-O-pentoside; flavones: apigenin-O-hexoside derivative, tricetin trimethyl ether 7-O-hexosyl-hexoside, tricin 7-O-glucoronyl-O-hexoside, tricin O-pentoside, and tricin-O-dihexoside; flavanones: eriodictyol-7-O-glucoside; flavan-3-ols: gallocatechin, hydroxycinnamic acid caffeoylmalic acid, and di-O-caffeoylquinic acid; coumarins: esculetin; esculin: fraxin; and lignans: hinokinin, pinoresinol, L-ascorbic acid, glucaric acid, palmitic acid, and linolenic acid. The results of supercritical CO<sub>2</sub>-extraction from roots and rhizomes of <i>Rh. rosea</i>, in particular, indicate that the extract contained all biologically active components of the plant, as well as inert mixtures of extracted compositions.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"9957490"},"PeriodicalIF":3.0,"publicationDate":"2021-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279876/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39220532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-06-22eCollection Date: 2021-01-01DOI: 10.1155/2021/5599204
Seyyed Mojtaba Mousavi, Seyyed Alireza Hashemi, Seyed Mohammad Iman Moezzi, Navid Ravan, Ahmad Gholami, Chin Wei Lai, Wei-Hung Chiang, Navid Omidifar, Khadije Yousefi, Gity Behbudi
Nowadays, pollution of the environment is a huge problem for humans and other organisms' health. Conventional methods of pollutant removal like membrane filtration or ion exchange are not efficient enough to lower the number of pollutants to standard levels. Biological methods, because of their higher efficiency and biocompatibility, are preferred for the remediation of pollutants. These cost-effective and environment-friendly methods of reducing pollutants are called bioremediation. In bioremediation methods, enzymes play the most crucial role. Enzymes can remedy different types of organic and inorganic pollutants, including PAHs, azo dyes, polymers, organocyanides, lead, chromium, and mercury. Different enzymes isolated from various species have been used for the bioremediation of pollutants. Discovering new enzymes and new subtypes with specific physicochemical characteristics would be a promising way to find more efficient and cost-effective tools for the remediation of pollutants.
{"title":"Recent Advances in Enzymes for the Bioremediation of Pollutants.","authors":"Seyyed Mojtaba Mousavi, Seyyed Alireza Hashemi, Seyed Mohammad Iman Moezzi, Navid Ravan, Ahmad Gholami, Chin Wei Lai, Wei-Hung Chiang, Navid Omidifar, Khadije Yousefi, Gity Behbudi","doi":"10.1155/2021/5599204","DOIUrl":"https://doi.org/10.1155/2021/5599204","url":null,"abstract":"<p><p>Nowadays, pollution of the environment is a huge problem for humans and other organisms' health. Conventional methods of pollutant removal like membrane filtration or ion exchange are not efficient enough to lower the number of pollutants to standard levels. Biological methods, because of their higher efficiency and biocompatibility, are preferred for the remediation of pollutants. These cost-effective and environment-friendly methods of reducing pollutants are called bioremediation. In bioremediation methods, enzymes play the most crucial role. Enzymes can remedy different types of organic and inorganic pollutants, including PAHs, azo dyes, polymers, organocyanides, lead, chromium, and mercury. Different enzymes isolated from various species have been used for the bioremediation of pollutants. Discovering new enzymes and new subtypes with specific physicochemical characteristics would be a promising way to find more efficient and cost-effective tools for the remediation of pollutants.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"5599204"},"PeriodicalIF":3.0,"publicationDate":"2021-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364428/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39319718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-06-22eCollection Date: 2021-01-01DOI: 10.1155/2021/9971857
Michael Konney Laryea, Lawrence Sheringham Borquaye
In many parts of the world, malaria undoubtedly poses a serious threat to health care systems. Malaria treatment has increasingly become complicated, primarily due to the emergence of widespread resistance of the malaria parasites to cheap and affordable malaria therapeutics. The use of herbal remedies to treat various ailments, including malaria and malaria-like ailments in Ghana is common. We herein report on the antiplasmodial and antioxidant activities as well as toxicological evaluation of four medicinal plants (Celtis africana, Grosseria vignei, Physalis micrantha, and Stachytarpheta angustifolia) commonly used to treat malaria in Ghana. Following Soxhlet extraction of plant samples in ethanol, extracts were screened against Plasmodium falciparum (3D7 strain) in an in vitro antiplasmodial assay. The phosphomolybdenum and DPPH (1, 1-diphenyl-2 picrylhydrazyl) assays were used to evaluate antioxidant activities while toxicity assessment was carried out in mice using the acute toxicity test and kidney and liver function tests. Extracts from Celtis africana and Physalis micrantha were very active towards the parasites with half-maximal inhibitory concentrations (IC50's) of 29.1 and 3.5 µg/mL, respectively. Extracts of Grosseria vignei and Stachytarpheta angustifolia were inactive, having IC50 values greater than 50 µg/mL. All extracts exhibited excellent total antioxidant capacities (>800 mg/g AAE) and good DPPH radical scavenging potential (IC50 range of 300-900 µg/mL). The median lethal dose (LD50) of all extracts in the toxicological evaluation was greater than 2000 mg/kg and there was no effect of extracts on the levels and activities of key biomarkers of liver and kidney function. The activities of these plants obtained in this study partly give credence to their folkloric use in herbal medicines and suggest that they could provide promising lead compounds for malaria drug discovery programs.
{"title":"Antimalarial, Antioxidant, and Toxicological Evaluation of Extracts of <i>Celtis africana</i>, <i>Grosseria vignei</i>, <i>Physalis micrantha</i>, and <i>Stachytarpheta angustifolia</i>.","authors":"Michael Konney Laryea, Lawrence Sheringham Borquaye","doi":"10.1155/2021/9971857","DOIUrl":"10.1155/2021/9971857","url":null,"abstract":"<p><p>In many parts of the world, malaria undoubtedly poses a serious threat to health care systems. Malaria treatment has increasingly become complicated, primarily due to the emergence of widespread resistance of the malaria parasites to cheap and affordable malaria therapeutics. The use of herbal remedies to treat various ailments, including malaria and malaria-like ailments in Ghana is common. We herein report on the antiplasmodial and antioxidant activities as well as toxicological evaluation of four medicinal plants (<i>Celtis africana</i>, <i>Grosseria vignei</i>, <i>Physalis micrantha</i>, and <i>Stachytarpheta angustifolia)</i> commonly used to treat malaria in Ghana. Following Soxhlet extraction of plant samples in ethanol, extracts were screened against <i>Plasmodium falciparum</i> (3D7 strain) in an <i>in vitro</i> antiplasmodial assay. The phosphomolybdenum and DPPH (1, 1-diphenyl-2 picrylhydrazyl) assays were used to evaluate antioxidant activities while toxicity assessment was carried out in mice using the acute toxicity test and kidney and liver function tests. Extracts from <i>Celtis africana</i> and <i>Physalis micrantha</i> were very active towards the parasites with half-maximal inhibitory concentrations (IC<sub>50</sub>'s) of 29.1 and 3.5 <i>µ</i>g/mL, respectively. Extracts of <i>Grosseria vignei</i> and <i>Stachytarpheta angustifolia</i> were inactive, having IC<sub>50</sub> values greater than 50 <i>µ</i>g/mL. All extracts exhibited excellent total antioxidant capacities (>800 mg/g AAE) and good DPPH radical scavenging potential (IC<sub>50</sub> range of 300-900 <i>µ</i>g/mL). The median lethal dose (LD<sub>50</sub>) of all extracts in the toxicological evaluation was greater than 2000 mg/kg and there was no effect of extracts on the levels and activities of key biomarkers of liver and kidney function. The activities of these plants obtained in this study partly give credence to their folkloric use in herbal medicines and suggest that they could provide promising lead compounds for malaria drug discovery programs.</p>","PeriodicalId":8826,"journal":{"name":"Biochemistry Research International","volume":"2021 ","pages":"9971857"},"PeriodicalIF":3.4,"publicationDate":"2021-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245231/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39181847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}